sorts, endemic and epidemic post-streptococcal glomerulonephritis, excessive adult weight gain with its syndrome X metabolic accompaniments, lung disease, heavy drinking and high rates of smoking. [7] [8] [9] Renal disease, as evidenced by an increased urinary albumin/creatinine ratio (ACR, g/mol), was pervasive, with only 29% of adults (20+ years) having a 'normal' ACR (< 1.1), while 23% had microalbuminuria (ACR 3.4-33) and 30% had overt albuminuria (ACR 34+). 8, 9 On cross-sectional review of the community profile, there was a progressive increase in ACR with increasing age (Fig. 2 ). There was a hint of higher estimated glomerular filtration rates (GFRs) 10 in individuals with subtle levels of pathological albuminuria and clearly tions, 1,2 as well as renal disease and renal failure. Deaths from renal disease have increased 18-to 30-fold, and the incidence of treated end-stage renal disease (ESRD) is approaching 1000 per million, and, until recently, has been doubling every 3-4 years, as shown in Fig. 1 . 3, 4 The rise in numbers of people receiving treatment for ESRD in the early and mid-1980s is probably due, in part, to increased ascertainment and referral, but later increases have been real. Currently, 96% of persons on dialysis in the Northern Territory are Aboriginal, although Aborigines constitute only 28% of the population. The costs of ESRD treatment have attracted especial concern, with the annual maintenance of a person on haemodialysis (the main form of treatment) plus their intercurrent hospitalizations estimated at more than A$100 000 in 1996-8. 5 Quality of life on ESRD treatment is poor, and survival is often short. 4 We have studied the renal disease that underlies this epidemic of renal failure, with the principal purpose of identifying solutions. Along the way we have illuminated risk factors, and mechanisms, for disease that can probably be generalized not only to other high-risk groups, but to the broader population.
STUDIES IN A HIGH-RISK COMMUNITY
The study was based in a remote island community (population about 1680, > 80% participation) whose annual ESRD incidence peaked at 2706 per million between 1993 and 1996, and whose recent cardiovascular death rates are six times those of an age-matched affluent non-Aboriginal population living in Canberra, Australia's capital. 6 In a simple clinical and biochemical examination, we identified pathology in abundance: low birthweight, childhood malnutrition, infections of many lower GFRs in individuals with progressively higher levels of overt albuminuria (Fig. 3) . In a longitudinal study of 581 adults (follow-up 1-8 years, mean 3.9 years), ACR increased and GFR fell in individuals with time, at rates that were strongly correlated with the severity of disease at baseline. Renal failure developed only in people with ACR levels > 100 g/mol at baseline. 11 The intensity of baseline ACR was associated not only with renal disease and its progression, but also, over a continuum, with subsequent natural deaths (Fig. 4) . These deaths included, but were not restricted to, cardiovascular deaths. This association persisted after accounting for age and sex, with a hazard ratio (95% CI) of 3.5 (0.8-15.3) in persons with microalbumiuria compared with those of lower ACRs and of 7.8 (1.9-33.2) for those with overt albuminuria at baseline. Thus, ACR is an indicator of mortality rate in this population. 11, 12 Using the ACR as a continuous and categorical variable, we evaluated its correlations with clinical and biochemical parameters measured in the screening examination. This list is not exhaustive, because the associations probed were constrained by the hypotheses proposed and the limited tools and resources available for their study. Factors that correlated significantly with ACR, and therefore with loss of renal function, cardiovascular disease and risk of natural death, [8] [9] [10] [11] [12] [13] [14] were as follows: 1. ageing; 2. low birthweight and infant malnutrition; 3. adult weight with excessive central fat deposition, and its attendant high blood pressure, dyslipidaemia, hyperinsulinaemia, dysglycaemia and diabetes; 4. infections, including skin sores and scabies; 5. remote episodes of post-streptococcal glomerulonephritis; 6. heavy drinking, marked by a high g-glutamyl transferase level; 7. multiparity in women (≥ 3 children); and 8. a family history of renal disease.
Estimates of risk enhancement for the presence of overt albuminuria associated with various 'diagnoses' in these categories are substantial, and have been reported previously. 8, 9 We thus propose a multideterminant rather than single-cause model of renal disease in which the simultaneous operation of several risk factors progressively enhance the increase in albuminuria that accompanies increasing age. Figure 5 , predicted from a multivariate model, 8, 9 illustrates this phenomenon in all adults. It shows that overt renal disease is almost inevitable by middle life in people with a full menu of risk factors (a fairly common situation), and that rates of renal disease in persons with no risk factors are much lower at all ages, although still substantial. Figure 6a and b illustrates this phenomenon for adults in whom birthweights were recorded, and shows why the effects of a single risk factor (in this case low birthweight), might be obscured or overlooked in a low-risk environment.
14 A similar amplifying Fig. 3 Correlation between albumin/creatinine ratio and glomerular filtration rate on baseline screen (adjusted for age, sex and body-mass index).
Fig. 4
Albumin/creatinine ratio and cumulative mortality for natural deaths (adjusted for age and sex). Fig. 5 Predicted probability of overt albuminuria in adults.
adjusted kidney volume and birthweight in children in this community (Fig. 7) , which supports a link between nephron endowment and intrauterine growth. 16 In view of the fourfold difference in nephron number described in the general population, 17 any hypothetical nephron 'deficit' might also have a genetic component. This is likely to be adaptive; a smaller number of nephrons might have been entirely adequate in the previous subsistence state, or even a survival advantage in conditions of salt and water deprivation.
Findings in 'diseased' Aboriginal biopsies are compatible with these hypotheses. All the usual morphological model can be constructed for the risk of microalbuminuria in young persons (< 30 years) based on interactions of age, female sex, blood pressure and a remote history (> 4 years previously) of post-streptococcal glomerulonephritis.
Our studies suggest that reduced nephron endowment or impaired nephron maturation might predispose to renal disease. These findings are reflected in the lower renal mass in autopsy studies and lower renal volume on ultrasound in some Aboriginal people. 15, 16 This is probably related, in part, to intrauterine growth retardation and infant malnutrition. 13, 14 We have demonstrated a continuous relationship between body-surface-area- diagnoses are represented, but the diversity of findings and lack of specificity of many biopsies make them a poor fit for particular morphological or 'aetiological' categories. 18, 19 The single consistent finding is glomerulomegaly, often with other changes than glomerular sclerosis. [18] [19] [20] This probably represents excessive nephron hypertrophy, resulting perhaps from an excess of trophic factors in the post-natal environment, as well as compensatory hypertrophy in individuals with reduced nephron numbers. Hyperperfusion and progressive sclerosis in excessively hypertrophied nephrons provide theoretical mechanisms for increasing albuminuria and accelerated nephron death.
Health and community services exert a powerful influence on the expression of renal (and other chronic) diseases, by influencing risk factors, natural history and survival. Risk is reduced by environmental improvements, better infant and childhood nutrition, antiscabies programmes and containment of epidemics of post-streptococcal glomerulonephritis, while a vaccine against nephritogenic streptococci is eagerly awaited. Paradoxically, however, improved services can facilitate disease expression. Dramatic reductions in infant mortality since the 1960s, due to better hospital management of sick babies, have resulted in large cohorts of lowbirthweight infants now surviving to adult life 13, 14 who are at high risk of renal and other chronic diseases. This phenomenon will abate if birthweights continue to improve. In addition, better management of infections, diabetes, cardiovascular morbidity (angioplasties, bypass procedures, etc.) in high-risk patients, and progressive effacement of the 20+ year mean survival differential between Aborigines and non-Aboriginal Australians through general improvements in health will lend more opportunity for nephropathy to run its fairly slow course to renal failure.
These considerations underpin arguments to systematically detect and modify disease progression in people already afflicted, the ultimate deliberate environmental influence. To this end, we introduced a treatment programme into the study community in late 1995, using the long-acting angiotensin-converting enzyme (ACE) inhibitor perindopril (Coversyl, Servier, Australia) as the primary agent. [21] [22] [23] [24] [25] Eligibility criteria were hypertension (systolic blood pressure ≥ 140 or diastolic blood pressure ≥ 90 mmHg), diabetes with ACR 3.4+ (microalbuminuria threshhold) regardless of blood pressure and overt albuminuria (ACR 34+) that was progressing regardless of blood pressure and diabetes status.
By December 1998, 240 people, or 26% of the entire adult population, had enrolled: 46% were diabetic, 64% hypertensive and 67% had overt albuminuria. Participation was enthusiastic, and compliance good in 70%. 24 Analysis at 3 years showed a dramatic and sustained fall in blood pressures, and stabilization of ACR (previously rising) and of GFR (previously falling) on a group basis. It also showed an estimated 62% reduction in combined endpoints of natural death and renal failure when compared with an historical cohort matched for disease severity in the pre-programme era. Such benefit applied at all levels of disease severity in persons with overt albuminuria, in whom most of the events were segregated, is shown in Fig. 8 . Community rates of ESRD and natural deaths support these estimates. We estimate savings on dialysis costs alone in this small community between A$700 000 and A$3.1 million, in the first 3 years of the programme, depending on whether ESRD and death rates would have continued to escalate or achieved a plateau in its absence. 25 The reduction in morbidity and mortality is, however, the greater human gain.
CONCLUSIONS
Renal disease in this population is multideterminant, with the excess of disease associated with a high density and multiplicity of nephropathic factors operating in a high-risk environment. Renal disease is intimately related to the general health profile and other chronic 'disease' states, and tightly correlated with overall mortality. 26 Risk factors derive from, or are exacerbated by, rapid transition, poverty and disadvantage, and the deficiencies and successes of health services. Environmental factors have undoubtedly also influenced genotypes over time.
Prevention depends on sustained improvements in socio-economic circumstances, infrastructure and health services. Concerns over ESRD treatment costs might yet prompt such changes. For persons already afflicted, disease is easily diagnosed and progression is dramatically altered by interventions within our reach. 27 Control of blood pressure, adult weight and infections are especially important. Pharmacological intervention will postpone ESRD and reduce premature death in early and middle adult life, and might postpone renal failure beyond reasonable life expectancies in many people.
Meanwhile, we must advocate for intersectoral initiatives to improve the environmental and socio-economic circumstances of high-risk populations. In our academic domains, we should foster interspecialty collaboration with the aim of developing a coherent unified approach to these health issues. We must redirect significant intellectual and material resources from expensive high-technology, diagnostic and interventional tracks in metropolitan hospitals towards issues of prevention and disease modification. Sociological, public health and community perspectives should be incorporated into specialist training, and mentorship and granting arrangements fostered in these disciplines. We should develop community-based health protocols, with defined goals, and accountability for outcomes. Improved health, greater longevity and reduced health care costs can probably be achieved over a shorter term than ever imagined.
